31st July 2020 - The global Manuka Honey Market is expected to display higher growth rate in the upcoming years. Rapid surge in the market is credited to the increasing number of application for medical purposes and rising distribution channels across the globe. Growing use of unconventional sweeteners and increasing the popularity of Manuka honey are expected to drive the growth of manuka honey market over the forecast period. Globally, market is predicted to generate massive revenue over the forecast period, providing numerous opportunities for industry participants to invest in research and development of manuka honey.
Manuka honey is a monofloral honey, which is derived from the fluid of the manuka tree, also called as Leptospermum scoparium. Increasing use of honey in traditional culture as an alternative medicine is expected to gain momentum over the coming years. In addition, recent research activities shows potential use of manuka honey for antibacterial medicines, thereby propelling market growth over the coming years.
Access Manuka Honey Market Report with TOC @ https://www.millioninsights.com/industry-reports/manuka-honey-market-report
HFCS-free manuka honey is gaining widespread popularity among consumers across the globe due to rising demand for chemical free honey products. HFCS-free manuka honey currently holds a major share and is estimated to rise over the coming years. The swift rise in demand of manuka honey is credited to the increasing awareness regarding the severe effect of consumption of high fructose corn syrup. Subsequently, organic manuka honey has gained a wide recognition over the past few years.
The manuka honey market is broadly categorized into major segments based on the application type such as food & beverage industry, cosmetics sector, nutraceuticals/natural health and medical product categories. Medical segment is growing rapidly in the market with substantial revenue generation in the last few years. Growing popularity of manuka honey segment is attributed to the increasing product penetration and rising number of online distribution channels.
Global Manuka Honey market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
- Comvita
- Manuka Health
- Arataki Honey
- Watson & Son
- Streamland
- Pure Honey New Zealand
- KirksBees Honey
- Capilano
- Nature's Way
Request a Sample Copy of Manuka Honey Market Report @ https://www.millioninsights.com/industry-reports/manuka-honey-market-report/request-sample
Geographically, this report is segmented into several key Regions, with production, consumption, revenue (M USD), market share and growth rate of Manuka Honey in these regions, from 2012 to 2023 (forecast), covering
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Columbia)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Visit Our Blog: https://marketreportsassistance.wordpress.com
Get in touch
At Million Insights, we work with the aim to reach the highest levels of customer satisfaction. Our representatives strive to understand diverse client requirements and cater to the same with the most innovative and functional solutions.
Contact Person:
Ryan Manuel
Research Support Specialist, USA
Email: [email protected]
Million Insights
Office No. 302, 3rd Floor, Manikchand Galleria,
Model Colony, Shivaji Nagar, Pune, MH, 411016 India
Phone: 91-20-65300184
Email: [email protected]
Jan 22, 2021: Industry InsightsThe global Extracorporeal Membrane Oxygenation (ECMO) market size was valued at USD 246.5 million in 2016 and is expected to grow at CAGR of 4.3% over the forecast period.
The major factors boosting growth are the rising incidences of Chronic Obstructive Pulmonary Disorder (COPD), and surging prevalence of cardiopulmonary diseases and respiratory failures.According to data recorded by the American Lung Association (ALA), in 2013, COPD was recorded to be the third largest cause of death across the U.S.
In addition, over 24.0 million individuals are estimated to remain undiagnosed in the U.S. and 11.0 million diagnosed for COPD.Also, the increasing adoption of unhealthy lifestyles, such as rise in the total tobacco consumption level among both, females and males and further development of lifestyle disorders are augmenting the incidence rate of COPD.
The segments are further segmented on the basis of who is using the set up into adult application, neonate and pediatric.
The segment dominating the market in 2015 with about 40.0% of the industry share is respiratory based ECMO.The increasing demand for the ECMO systems is majorly attributed to rising number of patients with chronic respiratory conditions like COPD, emphysema and chronic bronchitis combined with a trend of growing awareness about health disorders.
As per the U.S. National Center for Health Statistics, more than 8.7 million individuals suffered from chronic bronchitis and 3.4 million individuals suffered from emphysema in the year 2014.Regional InsightsThe major regions in this market are North America, Europe, Asia Pacific, Latin America and MEA.
Industry InsightsThe global Extracorporeal Membrane Oxygenation (ECMO) market size was valued at USD 246.5 million in 2016 and is expected to grow at CAGR of 4.3% over the forecast period.
The major factors boosting growth are the rising incidences of Chronic Obstructive Pulmonary Disorder (COPD), and surging prevalence of cardiopulmonary diseases and respiratory failures.According to data recorded by the American Lung Association (ALA), in 2013, COPD was recorded to be the third largest cause of death across the U.S.
In addition, over 24.0 million individuals are estimated to remain undiagnosed in the U.S. and 11.0 million diagnosed for COPD.Also, the increasing adoption of unhealthy lifestyles, such as rise in the total tobacco consumption level among both, females and males and further development of lifestyle disorders are augmenting the incidence rate of COPD.
The segments are further segmented on the basis of who is using the set up into adult application, neonate and pediatric.
The segment dominating the market in 2015 with about 40.0% of the industry share is respiratory based ECMO.The increasing demand for the ECMO systems is majorly attributed to rising number of patients with chronic respiratory conditions like COPD, emphysema and chronic bronchitis combined with a trend of growing awareness about health disorders.
As per the U.S. National Center for Health Statistics, more than 8.7 million individuals suffered from chronic bronchitis and 3.4 million individuals suffered from emphysema in the year 2014.Regional InsightsThe major regions in this market are North America, Europe, Asia Pacific, Latin America and MEA.
Global amino acids market demand was estimated at 6.19 million tons in 2013, with historical consumption propelled by l-glutamine and lysine’s application in dietary supplements and animal feed respectively.
Increasing meat consumption which has further driven livestock production will be a source for amino acids demand in future.
Countries such as Vietnam, Australia, and the Philippines have registered tremendous increase in pork, cattle and swine production in the recent years.
This trend is expected to continue in the future course, which will cast a positive influence on the industry dynamics.
Glutamine is widely used as an additive in food & dietary supplement and therefore marketed as medical food.
Standardization of animal feed ingredient usage across various developing markets, particularly that of Asia, will provide impetus for producers to specialize their product offerings for feed industry.
19 February 2020 - The global Gene Expression Market is estimated to reach USD 11.3 billion by 2025.
Market is also expected to grow at a decent rate over the forecast period driven by rising number of cancer patients, facilities for financial funding, decreased cost of sequencing, and high concentration on research & development.
In emerging economies, the industry offers advantageous opportunities for growth with rising concentration on adoption and precision as well as personalization in medicines.
However, currency devaluation in developing economies and initial capital investment of different instruments are considered as restraint as well as challenge for the industry.The gene expression is a set of steps for a functional genetic code product occur in the synthesis, with the support of the data coded on genes.
The process is prominent in multi cellular organisms as well as bacteria such as eukaryotes or prokaryotes, which ensure the creation of machinery macro molecular of their life.Request a Sample Copy of This Report @ https://www.millioninsights.com/industry-reports/gene-expression-analysis-marketIn context with the consumables of gene expressions, the industry is classified into DNA chips and reagents.
Aforementioned factor would drive the demand for profiling services over the forecast period.The genetic code expression includes translation and transcription process.
USA: November 5, 2019- Extracorporeal Membrane Oxygenation (ECMO) Market size was valued at USD 246.5 million in 2016 and is expected to grow at CAGR of 4.3% over the forecast period.
The major factors boosting growth are the rising incidences of Chronic Obstructive Pulmonary Disorder (COPD), and surging prevalence of cardiopulmonary diseases and respiratory failures.According to data recorded by the American Lung Association (ALA), in 2013, COPD was recorded to be the third largest cause of death across the U.S.
In addition, over 24.0 million individuals are estimated to remain undiagnosed in the U.S. and 11.0 million diagnosed for COPD.To Get Sample Report visit @ https://www.millioninsights.com/industry-reports/extracorporeal-membrane-oxygenation-ecmo-market/request-sampleAlso, the increasing adoption of unhealthy lifestyles, such as rise in the total tobacco consumption level among both, females and males and further development of lifestyle disorders are augmenting the incidence rate of COPD.
ECMO machines are gaining popularity in the hospital and healthcare systems due to the rising trend of its application during cases of respiratory disorders.The ECMO machines are used in cases of cardiac failure to facilitate auxiliary oxygen support system.
The segments are further segmented on the basis of who is using the set up into adult application, neonate and pediatric.
The segment dominating the market in 2015 with about 40.0% of the industry share is respiratory based ECMO.The increasing demand for the ECMO systems is majorly attributed to rising number of patients with chronic respiratory conditions like COPD, emphysema and chronic bronchitis combined with a trend of growing awareness about health disorders.
The Medical Cyclotron Market was appreciated by US$ 118.2 million in the year of 2016.
Growing occurrence of cancer, increasing preference towards nuclear-powered images for precise judgement, price benefit as equated to subcontracted emitting radiation tracers, and obtainability of technically innovative analytical devices are between important tendencies activating the progress of the market.
By the source of geography, Asia Pacific was responsible for the uppermost stake in the market during the year 2016.
Therefore, Japan observed the setting up of the maximum number of new-fangled particle accelerators and is composed to set up 49 novel accelerators by 2025.
The statement revises Trades in terms of intake of medical cyclotron in the market; particularly in North America, Europe, Asia Pacific, Latin America, Middle East & Africa.
Yet, more or less companies for example TeamBest is evolving an inventive product by way of the capability of 400 MeV for particle therapy through weighty ions.
